Effect of sustained release on the pharmacokinetic profile of indomethacin in man
- 1 July 1982
- journal article
- clinical trial
- Published by Wiley in Biopharmaceutics & Drug Disposition
- Vol. 3 (3) , 219-230
- https://doi.org/10.1002/bdd.2510030305
Abstract
The effect of sustained release on the pharmacokinetic profile of indomethacin was examined by comparing to three reference regimens: an intravenous dose, a single 75 mg dose of conventional capsules, and three 25 mg conventional doses given at 4‐h intervals. Results indicate that the sustained release test formulation exhibited more prolonged and uniform absorption rate, yielded more sustained plasma levels after ingestion, and showed an overall bioavailability of 0.93 (95 per cent C.I. = 0.82, 1.04) relative to three 25 mg doses of the conventional capsules.Keywords
This publication has 8 references indexed in Scilit:
- Kinetic Parameter Estimation by Numerical Algorithms and Multiple Linear Regression: Application to PharmacokineticsJournal of Pharmaceutical Sciences, 1979
- A comparison of numerical integrating algorithms by trapezoidal, Lagrange, and spline approximationJournal of Pharmacokinetics and Biopharmaceutics, 1978
- Indomethacin serum concentrations in man. Effects of dosage, food, and antacid.Annals of the Rheumatic Diseases, 1976
- Kinetics of indomethacin absorption, elimination, and enterohepatic circulation in manJournal of Pharmacokinetics and Biopharmaceutics, 1976
- Novel Method for Bioavailability AssessmentJournal of Pharmaceutical Sciences, 1973
- Role of the entero-hepatic cycle of indomethacin on its metabolism, distribution in tissues and its excretion by rats, dogs and monkeysBiochemical Pharmacology, 1970
- New Method for Calculating the Intrinsic Absorption Rate of DrugsJournal of Pharmaceutical Sciences, 1968
- Shortcomings in Pharmacokinetic Analysis by Conceiving the Body to Exhibit Properties of a Single CompartmentJournal of Pharmaceutical Sciences, 1968